BioGredient II ApS: Financial statements 2021
CVR: 37759724
Source: annual report 2021, Danish Business Authority
01/07/2020 – 30/06/2021
BioGredient II ApS (CVR 37759724) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2021 report amounted to DKK 0.
- Profit/Loss
- DKK 0
- Equity
- DKK 0
- Total Assets
- DKK 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | 0 | 0 | - |
| 2020 | - | - | 0 | 0 | - |
| 2019 | - | 0 | 0 | 0 | - |
| 2018 | - | - | -40 t. | 0 | - |
| 2017 | - | - | -10 t. | 40 t. | - |
Official annual report
Find more companies like BioGredient II ApS
Build lead lists with filters on industry, geography, size and financials, and export straight to Excel.
Try the lead list generatorEvents in 2021
On June 11, 2021, the company changed its name from Nordic-Umami ApS to BioGredient II ApS.
As of May 18, 2021, Orla Møller Petersen is registered as director of BioGredient II ApS.
As of May 18, 2021, Peter Jensen has stepped down as director of BioGredient II ApS.
As of May 18, 2021, DACWR ApS is registered as an owner of BioGredient II ApS with an ownership share of 100%.
As of May 12, 2021, Peter Jensen is registered as director of BioGredient II ApS.
As of May 12, 2021, Orla Møller Petersen has stepped down as adm. dir. of BioGredient II ApS.
On May 12, 2021, the company changed its name from BioGredient II ApS to Nordic-Umami ApS.
About BioGredient II ApS
BioGredient II ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is under bankruptcy. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Nordic-Umami ApS. The company is owned by DACWR ApS. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a net result of DKK 0 compared with DKK 0 the year before. Equity in the 2025 report amounted to DKK -14,447.